Patritumab deruxtecan, with or without letrozole, showed similar efficacy to chemotherapy in high-risk HR-positive, HER2-negative breast cancer, with lower severe side effects. The SOLTI VALENTINE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback